BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2021538)

  • 1. The relationship between tissue levels of flavone acetic acid (NSC 347512) and site dependent anti-tumour activity in murine colon tumours.
    Bibby MC; Phillips RM; Double JA
    Br J Cancer; 1991 Apr; 63(4):541-5. PubMed ID: 2021538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512).
    Bibby MC; Phillips RM; Double JA
    Cancer Chemother Pharmacol; 1989; 24(2):87-94. PubMed ID: 2731316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512).
    Bibby MC; Double JA; Loadman PM
    Br J Cancer; 1988 Sep; 58(3):341-4. PubMed ID: 3179187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumour activity of flavone acetic acid (NSC 347512) in mice--influence of immune status.
    Bibby MC; Phillips RM; Double JA; Pratesi G
    Br J Cancer; 1991 Jan; 63(1):57-62. PubMed ID: 1989665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro.
    Chabot GG; Bissery MC; Gouyette A
    Cancer Chemother Pharmacol; 1989; 24(5):273-6. PubMed ID: 2758556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512).
    Pratesi G; Manzotti C; Damia G; D'Incalci M
    Br J Cancer; 1988 Aug; 58(2):144-6. PubMed ID: 3166904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice.
    Chabot GG; Bissery MC; Corbett TH; Rutkowski K; Baker LH
    Cancer Chemother Pharmacol; 1989; 24(1):15-22. PubMed ID: 2597279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of flavone acetic acid (NSC-347512) against solid tumors of mice.
    Corbett TH; Bissery MC; Wozniak A; Plowman J; Polin L; Tapazoglou E; Dieckman J; Valeriote F
    Invest New Drugs; 1986; 4(3):207-20. PubMed ID: 3546183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour concentrations of flavone acetic acid (FAA) in human melanoma: comparison with mouse data.
    Maughan TS; Ward R; Dennis I; Honess DJ; Workman P; Bleehen NM
    Br J Cancer; 1992 Sep; 66(3):579-82. PubMed ID: 1520597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 1: 6-Methyl derivatives.
    Aitken RA; Bibby MC; Double JA; Phillips RM; Sharma SK
    Arch Pharm (Weinheim); 1996 Nov; 329(11):489-97. PubMed ID: 8997898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses of experimental rat tumours and a mouse colon tumour to flavone acetic acid.
    Kal HB; de Graaff E; Van Berkel AH; Goedoen HH
    In Vivo; 1992; 6(1):73-5. PubMed ID: 1385730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumour activity of new derivatives of flavone-8-acetic acid (FAA). Part 2: Ring-substituted derivatives.
    Aitken RA; Bibby MC; Double JA; Laws AL; Ritchie RB; Wilson DW
    Arch Pharm (Weinheim); 1997 Jul; 330(7):215-24. PubMed ID: 9311301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and anti-tumour activity of LM985 in mice bearing transplantable adenocarcinomas of the colon.
    Double JA; Bibby MC; Loadman PM
    Br J Cancer; 1986 Oct; 54(4):595-600. PubMed ID: 3778803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the tissue distribution of ThioTEPA and its metabolite, TEPA, on the response of murine colon tumours.
    Bibby MC; McDermott BJ; Double JA; Phillips RM; Loadman PM; Burgess L
    Cancer Chemother Pharmacol; 1987; 20(3):203-6. PubMed ID: 2445497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid).
    Bibby MC; Double JA; Phillips RM; Loadman PM
    Br J Cancer; 1987 Feb; 55(2):159-63. PubMed ID: 3814485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of antitumor effects of flavone acetic acid by cortisone.
    Ching LM; Joseph WR; Baguley BC
    Anticancer Res; 1993; 13(4):1139-41. PubMed ID: 8352536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide: its production in host-cell-infiltrated EMT6 spheroids and its role in tumour cell killing by flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid.
    Thomsen LL; Baguley BC; Wilson WR
    Cancer Chemother Pharmacol; 1992; 31(2):151-5. PubMed ID: 1451234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid.
    Ching LM; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1061-5. PubMed ID: 2597283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new flavone-8-acetic acid metabolites using mouse microsomes and comparison with human microsomes.
    Pham MH; Auzeil N; Regazzetti A; Dauzonne D; Dugay A; Menet MC; Scherman D; Chabot GG
    Drug Metab Dispos; 2007 Nov; 35(11):2023-34. PubMed ID: 17664249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.
    Laws AL; Matthew AM; Double JA; Bibby MC
    Br J Cancer; 1995 Jun; 71(6):1204-9. PubMed ID: 7779712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.